Overview
Liver Function Assessment - Feasibility and Dosing Study
Status:
Terminated
Terminated
Trial end date:
2016-01-01
2016-01-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to 1) determine the feasibility of using Cardiox Liver Function Assessment System (LFA) to measure indocyanine green (ICG) clearance; 2) determine an adequate dose based on LFA technology and 3) determine an adequate time period for LFA determination.Phase:
N/AAccepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Cardiox Corporation
Criteria
Inclusion Criteria:- Male or female subjects, aged 18 to 75 years, inclusive
- Informed consent documentation understood and signed.
Exclusion Criteria:
- Known allergy or sensitivity to the ICG or to iodide contrast dye
- Pregnant women or those nursing babies